- Home
- TKNO vs BBOT Comparison
TKNO vs BBOT Comparison
Compare TKNO & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKNO | BBOT |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.7M | 442.6M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TKNO | BBOT |
|---|---|---|
| Price | $7.33 | $2.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | $9.67 | ★ $23.55 |
| AVG Volume (30 Days) | ★ 651.2K | 569.8K |
| Earning Date | 11-04-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.86 | ★ 99.93 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,520,000.00 | N/A |
| Revenue This Year | $13.54 | N/A |
| Revenue Next Year | $14.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $1.91 | $2.29 |
| 52 Week High | $9.48 | $14.87 |
Technical Indicators
Market Signals| Indicator | TKNO | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 20.61 |
| Support Level | $4.89 | N/A |
| Resistance Level | $7.66 | $9.36 |
| Average True Range (ATR) | 0.64 | 0.21 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 74.07 | 2.96 |
Price Performance
Historical ComparisonAbout TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.